The EHA Research Roadmap : Transfusion Medicine
(2022) In HemaSphere 6(2). p.1-6- Abstract
- In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1–2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including eleven sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent... (More)
- In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1–2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including eleven sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/9aade265-bd04-45fe-b4af-f2f864c10b8f
- author
- Stanworth, Simon J
; Brand, Anneke
; Kaveri, Srini V
; Vrielink, Hans
; Greinacher, Andreas
; Domanović, Dragoslav
; von Lindern, Marieke
; Allard, Shubha
; Bayry, Jagadeesh
; Bohonek, Milos
; Buser, Andreas
; Claas, Frans H J
; Knutson, Folke
; Lozano, Miguel
; Olsson, Martin L
LU
; Pirenne, France
; Rebulla, Paolo
; So-Osman, Cynthia
; Tissot, Jean-Daniel
; Toye, Ashley M
; Ushiro-Lumb, Ines
; van den Akker, Emile
and Zeerleder, Sacha
(Less) - organization
- publishing date
- 2022
- type
- Contribution to journal
- publication status
- published
- subject
- in
- HemaSphere
- volume
- 6
- issue
- 2
- article number
- e670
- pages
- 1 - 6
- publisher
- Wolters Kluwer
- external identifiers
-
- pmid:35098039
- scopus:85124178219
- ISSN
- 2572-9241
- DOI
- 10.1097/HS9.0000000000000670
- language
- English
- LU publication?
- yes
- id
- 9aade265-bd04-45fe-b4af-f2f864c10b8f
- date added to LUP
- 2022-02-10 10:53:29
- date last changed
- 2024-06-08 07:59:46
@misc{9aade265-bd04-45fe-b4af-f2f864c10b8f,
abstract = {{In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1–2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including eleven sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.}},
author = {{Stanworth, Simon J and Brand, Anneke and Kaveri, Srini V and Vrielink, Hans and Greinacher, Andreas and Domanović, Dragoslav and von Lindern, Marieke and Allard, Shubha and Bayry, Jagadeesh and Bohonek, Milos and Buser, Andreas and Claas, Frans H J and Knutson, Folke and Lozano, Miguel and Olsson, Martin L and Pirenne, France and Rebulla, Paolo and So-Osman, Cynthia and Tissot, Jean-Daniel and Toye, Ashley M and Ushiro-Lumb, Ines and van den Akker, Emile and Zeerleder, Sacha}},
issn = {{2572-9241}},
language = {{eng}},
number = {{2}},
pages = {{1--6}},
publisher = {{Wolters Kluwer}},
series = {{HemaSphere}},
title = {{The EHA Research Roadmap : Transfusion Medicine}},
url = {{http://dx.doi.org/10.1097/HS9.0000000000000670}},
doi = {{10.1097/HS9.0000000000000670}},
volume = {{6}},
year = {{2022}},
}